🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
Treatment with only protease inhibitors might benefit HIV patients. Laborat...
Status
Completed
Location
The HIV Netherlands Australia Thailand Research Collaboration
Start Date
2004-03
Trial ID
NCT00400738
Treatments Being Tested
This study will compare the benefit for patients switching from Kaletra® to...
Status
Completed
Location
Royal Free Hampstead NHS Trust
Start Date
2006-09
Trial ID
NCT00438152
Treatments Being Tested
The purpose of this randomized, open-label, multicenter, active-controlled ...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2010-11
Trial ID
NCT01252940
Treatments Being Tested
The goal of this clinical study is to learn more about the safety and dosin...
Status
Active Not Recruiting
Location
Pediatric Infectious Disease Associates
Start Date
2014-01-16
Trial ID
NCT02016924
Treatments Being Tested
The main objective of this study is to observe the long-term safety of elvi...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00445146
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
Spectrum Medical Group
Start Date
2015-11-18
Trial ID
NCT02605954
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of elvitegra...
Status
Completed
Location
Midway Immunology & Research Center, LLC
Start Date
2015-12-17
Trial ID
NCT02616029
Treatments Being Tested
The primary objective of this study is to evaluate the safety of elvitegrav...
Status
Completed
Location
CHU Saint-Pierre University Hospital
Start Date
2015-12-22
Trial ID
NCT02616783
The previous two studies of generic GPO saquinavir failed to prove bioequiv...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00622141
Treatments Being Tested